Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.85 |
| ▸ | MAOB | P27338 | 4/20 | 0.67 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.67 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.67 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.67 |
| ▸ | MAOA | P21397 | 1/20 | 0.67 |
| ▸ | ACHE | P22303 | 5/20 | 0.63 |
| ▸ | KDM4A | O75164 | 2/20 | 0.59 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29733117 | 1.00 | SIGMAR1 (0.85) | SIGMAR1MAOBCARM1PRMT6PRMT8 | |
| SCHEMBL16260101 | 0.94 | SIGMAR1 (0.76) | SIGMAR1MAOBCARM1PRMT6PRMT8 | |
| SCHEMBL1088446 | 0.93 | SIGMAR1 (0.74) | SIGMAR1MAOBCARM1PRMT6PRMT8 | |
| SCHEMBL7190739 | 0.92 | SIGMAR1 (0.73) | SIGMAR1MAOBCARM1PRMT6PRMT8 | |
| SCHEMBL2326491 | 0.92 | SIGMAR1 (0.73) | SIGMAR1MAOBCARM1PRMT6PRMT8 | |
| SCHEMBL9131293 | 0.92 | SIGMAR1 (0.73) | SIGMAR1MAOBCARM1PRMT6PRMT8 | |
| SCHEMBL10352566 | 0.92 | SIGMAR1 (0.73) | SIGMAR1MAOBCARM1PRMT6PRMT8 | |
| SCHEMBL278595 | 0.92 | SIGMAR1 (0.73) | SIGMAR1MAOBCARM1PRMT6PRMT8 | |
| SCHEMBL9275367 | 0.92 | SIGMAR1 (0.73) | SIGMAR1MAOBCARM1PRMT6PRMT8 | |
| SCHEMBL15966143 | 0.92 | SIGMAR1 (0.73) | SIGMAR1MAOBCARM1PRMT6PRMT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6576791-B1 | Local anesthetic compounds and uses | THERAVANCE, INC. | 2003-06-10 | — | — | US | disclosed |
| US-6495681-B1 | PRODUCING LOCAL ANESTHESIA OF LONG-DURATION. THE COMPOUNDS OF THIS INVENTION ARE MULTIBINDING COMPOUNDS THAT COMPRISE FROM 2 TO 10 LIGANDS COVALENTLY ATTACHED TO A LINKER OR LINKERS, EACH LIGAND BEING CAPABLE OF BINDING TO A LIGAND BINDING SITE | THERAVANCE INC. | 2002-12-17 | — | — | US | disclosed |
| US-6462034-B1 | MULTIBINDING COMPOUNDS CONTAINING A SYMETRICAL DIAMINOTETRA-ETHERDODECANE RING WITH TWO SECONDARY AMIDE AND ADDITIONAL SUBSTITUENTS; VOLTAGE GATED SODIUM CHANNEL MODULATORS; LONG DURATION | THERAVANCE, INC. | 2002-10-08 | — | — | US | disclosed |
| US-6337423-B1 | BIND TO VOLTAGE-GATED SODIUM ION CHANNELS TO MODULATE ACTIVITY | ADVANCED MEDICINE, INC. | 2002-01-08 | — | — | US | disclosed |
| EP-1066245-A4 | NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES | ADVANCED MEDICINE INC (US) | 2001-01-24 | — | — | EP | disclosed |
| EP-1066245-A1 | NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES | Advanced Medicine, Inc. (US) | 2001-01-10 | — | — | EP | disclosed |
| WO-1999051565-A9 | NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES | ADVANCED MEDICINE INC (US) | 1999-12-02 | — | — | WO | disclosed |
| WO-1999051565-A1 | NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES | ADVANCED MEDICINE, INC. (US) | 1999-10-14 | — | — | WO | disclosed |